Wound-healing spray moves to Phase III clinical trials

04/16/2013 | WTAJ-TV (Altoona, Pa.)

Patients are being recruited for Phase III clinical trials of a spray containing human cells that release growth factors into a wound to encourage tissue regeneration. Wounds treated with the spray were 52% more likely to heal than those treated with compression bandages in earlier trials.

View Full Article in:

WTAJ-TV (Altoona, Pa.)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
CareFusion
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ
Director, Site Quality Management
CareFusion
Minneapolis, MN
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC